Literature DB >> 26969414

Epigenetics: A primer for clinicians.

Benjamin E Paluch1, Abdul R Naqash2, Zachary Brumberger3, Michael J Nemeth4, Elizabeth A Griffiths5.   

Abstract

With recent advances in cellular biology, we now appreciate that modifications to DNA and histones can have a profound impact on transcription and function, even in the absence of changes to DNA sequence. These modifications, now commonly referred to as "epigenetic" alterations, have changed how we understand cell behavior, reprogramming and differentiation and have provided significant insight into the mechanisms underlying carcinogenesis. Epigenetic alterations, to this point, are largely identified by changes in DNA methylation and hydroxymethylation as well as methylation, acetylation, and phosphorylation of histone tails. These modifications enable significant flexibility in gene expression, rather than just turning genes "ON" or "OFF." Herein we describe the epigenetic landscape in the regulation of gene expression with a particular focus on interrogating DNA methylation in myeloid malignancy.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  5-Hydroxymethylcytosine (5HmC); 5-Methylcytosine (5mC); Cytosine phospho-guanine (CpG); DNA methyltransferases (DNMTs); DNMT inhibitor (DNMTi); Hypomethylating agent (HMA); Ten eleven translocation (TET)

Mesh:

Year:  2016        PMID: 26969414      PMCID: PMC5737767          DOI: 10.1016/j.blre.2016.02.002

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  243 in total

1.  Crystal structure of the nucleosome core particle at 2.8 A resolution.

Authors:  K Luger; A W Mäder; R K Richmond; D F Sargent; T J Richmond
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

Review 2.  X-inactivation, imprinting, and long noncoding RNAs in health and disease.

Authors:  Jeannie T Lee; Marisa S Bartolomei
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

3.  Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A.

Authors:  Marco Pieroni; Giannamaria Annunziato; Elisa Azzali; Paola Dessanti; Ciro Mercurio; Giuseppe Meroni; Paolo Trifiró; Paola Vianello; Manuela Villa; Claudia Beato; Mario Varasi; Gabriele Costantino
Journal:  Eur J Med Chem       Date:  2015-01-07       Impact factor: 6.514

4.  Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms.

Authors:  Steven D Gore; Stephen Baylin; Elizabeth Sugar; Hetty Carraway; Carole B Miller; Michael Carducci; Michael Grever; Oliver Galm; Tianna Dauses; Judith E Karp; Michelle A Rudek; Ming Zhao; B Douglas Smith; Jasper Manning; Anchalee Jiemjit; George Dover; Abbie Mays; James Zwiebel; Anthony Murgo; Li-Jun Weng; James G Herman
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

5.  Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.

Authors:  Philip Kahl; Lucia Gullotti; Lukas Carl Heukamp; Susanne Wolf; Nicolaus Friedrichs; Roland Vorreuther; Gerold Solleder; Patrick J Bastian; Jörg Ellinger; Eric Metzger; Roland Schüle; Reinhard Buettner
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

6.  Clonal inheritance of the pattern of DNA methylation in mouse cells.

Authors:  R Stein; Y Gruenbaum; Y Pollack; A Razin; H Cedar
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

7.  DNMT3A mutations in acute myeloid leukemia.

Authors:  Timothy J Ley; Li Ding; Matthew J Walter; Michael D McLellan; Tamara Lamprecht; David E Larson; Cyriac Kandoth; Jacqueline E Payton; Jack Baty; John Welch; Christopher C Harris; Cheryl F Lichti; R Reid Townsend; Robert S Fulton; David J Dooling; Daniel C Koboldt; Heather Schmidt; Qunyuan Zhang; John R Osborne; Ling Lin; Michelle O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Sean D McGrath; Lucinda A Fulton; Vincent J Magrini; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Joshua J Conyers; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd Wylie; Jason Walker; Joelle Kalicki; Mark A Watson; Sharon Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Peter Westervelt; Michael H Tomasson; Daniel C Link; Timothy A Graubert; John F DiPersio; Elaine R Mardis; Richard K Wilson
Journal:  N Engl J Med       Date:  2010-11-10       Impact factor: 91.245

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Immunomodulatory activity of SGI-110, a 5-aza-2'-deoxycytidine-containing demethylating dinucleotide.

Authors:  Sandra Coral; Giulia Parisi; Hugues J M G Nicolay; Francesca Colizzi; Riccardo Danielli; Elisabetta Fratta; Alessia Covre; Pietro Taverna; Luca Sigalotti; Michele Maio
Journal:  Cancer Immunol Immunother       Date:  2012-11-09       Impact factor: 6.968

10.  Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.

Authors:  Mark A Dawson; Rab K Prinjha; Antje Dittmann; George Giotopoulos; Marcus Bantscheff; Wai-In Chan; Samuel C Robson; Chun-wa Chung; Carsten Hopf; Mikhail M Savitski; Carola Huthmacher; Emma Gudgin; Dave Lugo; Soren Beinke; Trevor D Chapman; Emma J Roberts; Peter E Soden; Kurt R Auger; Olivier Mirguet; Konstanze Doehner; Ruud Delwel; Alan K Burnett; Phillip Jeffrey; Gerard Drewes; Kevin Lee; Brian J P Huntly; Tony Kouzarides
Journal:  Nature       Date:  2011-10-02       Impact factor: 49.962

View more
  14 in total

1.  Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.

Authors:  Feng Chen; Xueyi Li; Emily Aquadro; Stephen Haigh; Jiliang Zhou; David W Stepp; Neal L Weintraub; Scott A Barman; David J R Fulton
Journal:  Free Radic Biol Med       Date:  2016-08-03       Impact factor: 7.376

2.  The development and validation of EpiComet-Chip, a modified high-throughput comet assay for the assessment of DNA methylation status.

Authors:  Todd A Townsend; Marcus C Parrish; Bevin P Engelward; Mugimane G Manjanatha
Journal:  Environ Mol Mutagen       Date:  2017-07-29       Impact factor: 3.216

3.  Wnt signalling meets epigenetics.

Authors:  Frank J T Staal
Journal:  Stem Cell Investig       Date:  2016-08-12

Review 4.  Detangling the interrelations between MAFLD, insulin resistance, and key hormones.

Authors:  Shreya C Pal; Mohammed Eslam; Nahum Mendez-Sanchez
Journal:  Hormones (Athens)       Date:  2022-08-03       Impact factor: 3.419

5.  DNA methylation in spermatogenesis and male infertility.

Authors:  Xiangrong Cui; Xuan Jing; Xueqing Wu; Meiqin Yan; Qiang Li; Yan Shen; Zhenqiang Wang
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

6.  Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.

Authors:  Xuguang Zhu; Keisuke Enomoto; Li Zhao; Yuelin J Zhu; Mark C Willingham; Paul Meltzer; Jun Qi; Sheue-Yann Cheng
Journal:  Clin Cancer Res       Date:  2016-07-20       Impact factor: 12.531

Review 7.  Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.

Authors:  William M Grady; Ming Yu; Sanford D Markowitz
Journal:  Gastroenterology       Date:  2020-12-03       Impact factor: 22.682

8.  NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome.

Authors:  Elizabeth A Griffiths; Pragya Srivastava; Junko Matsuzaki; Zachary Brumberger; Eunice S Wang; Justin Kocent; Austin Miller; Gregory W Roloff; Hong Yuen Wong; Benjamin E Paluch; Linda G Lutgen-Dunckley; Brandon L Martens; Kunle Odunsi; Adam R Karpf; Christopher S Hourigan; Michael J Nemeth
Journal:  Clin Cancer Res       Date:  2017-09-25       Impact factor: 13.801

Review 9.  Early-Life Nutritional Programming of Type 2 Diabetes: Experimental and Quasi-Experimental Evidence.

Authors:  Alexander M Vaiserman
Journal:  Nutrients       Date:  2017-03-05       Impact factor: 5.717

Review 10.  The well-accepted notion that gene amplification contributes to increased expression still remains, after all these years, a reasonable but unproven assumption.

Authors:  Yuping Jia; Lichan Chen; Qingwen Jia; Xixi Dou; Ningzhi Xu; Dezhong Joshua Liao
Journal:  J Carcinog       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.